people who want to learn about and take action on the world�s biggest challenges. extreme poverty ends with you. . . .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
. .